Investment Council: $UAA

Based on Turnaround Radar's research: "The Last Layer"

Under Armour's eroding moat — four of five evidence buckets trending negative — meets an expensive valuation at 21x trailing EV/EBITDA, 45% above its own five-year average. Investors are paying a turnaround premium that zero quarters of top-line growth have earned.

Under Armour's competitive position has deteriorated across nearly every measurable dimension over the past twelve months. The Trustpilot US profile carries an 84% one-star rate across 1,357 reviews, confirmed independently on SiteJabber at the same rate — a statistically significant gap above Nike's ~79% on the same platform. The dominant complaint pattern is returns and refunds dysfunction: DHL loses the return, Under Armour claims it arrived empty, refunds stall for 30+ days. This is a structural customer experience failure, not a perception issue.

The brand has lost its most important competitive asset. Stephen Curry signed a 10-year deal with Li-Ning after ending his 12-year Under Armour partnership — the single largest brand ambassador loss in the company's history. Combined with the earlier sale of MapMyFitness (80 million registered users), Under Armour has voluntarily shed the two assets that once differentiated it from commodity sportswear. Net Promoter Score of 30 ranks seventh among major brands, behind Nike, Adidas, New Balance, Puma, Reebok, and ASICS.

Pricing power is compressed. Gross margin fell from 47.9% in FY2025 to 45.5% in FY2026, with Q4 hitting 42.0% — 470 basis points below the prior year. While tariffs affect all peers, Under Armour's margin compression is disproportionate due to heavier reliance on promotions. Among peers: Nike holds 44-45%, Adidas ~50%, On Holdings ~60%. Under Armour sits at the bottom.

The competitive gap is widening in real time. On Holdings grew revenue 30% in FY2025, Hoka 24%. Under Armour's revenue has declined for three consecutive years — $5.7B to $5.2B to $5.0B — while footwear, the category where brand equity converts to growth, fell 11%. One bright spot: BBB complaints declined 44.7% year-over-year, a statistically significant improvement suggesting the operational infrastructure is slowly healing — even as the cumulative review damage persists.

The crisis is genuine but bounded. Under Armour's 89% decline from its all-time high reflects a multi-year sequence of real operating deterioration: North American revenue declined 8% in FY2026 (58% of sales), the company cycled through three CEOs in four years before Kevin Plank's return, and a 72.7-million-record data breach in November 2025 eroded digital trust at the worst possible moment. The most recent leg: a 17% stock crash on May 12 after Q4 FY2026 earnings missed by $0.01 and FY2027 EPS guidance of $0.08-$0.12 came in at roughly half of the $0.23 consensus.

The revenue decline is decelerating but has not reversed. DTC turned positive in Q4 FY2026 (+5% YoY), and e-commerce stabilized after consecutive -20% and -7% declines. The balance sheet is stressed but not distressed — $309 million in cash, debt refinanced at 7.25% (up from 3.25%), Moody's at B1 with 5.5x leverage. Approximately 260 basis points of the gross margin decline is attributable to tariffs rather than organic brand deterioration, but isolating the two precisely is the key analytical challenge.

The crisis is fixable if North America revenue stabilizes by mid-FY2027, if the $70 million IEEPA tariff refund materializes as management expects, and if DTC momentum accelerates as the Sports House concept scales. It is not fixable if wholesale channel loss proves permanent, if the brand cannot command full-price sell-through, or if the data breach class action produces material financial liability. Doom-loop risk is moderate — declining revenue, rising debt costs, and constrained marketing budgets create a reinforcing cycle, but Fairfax's capital backing provides runway.

Kevin Plank has diagnostic clarity — cutting 25% of product styles, closing the Rialto distribution center, replacing the C-suite, and launching the Sports House concept with only 96 curated styles. His communication mixes operational specifics ("sell a lot more of a lot less") with enough aspirational language to raise credibility questions when paired with a $496 million GAAP net loss. The fundamental issue: Plank built Under Armour from zero to $5 billion but presided over its decline from the 2015 peak. He has zero prior turnaround precedent.

The board has been materially upgraded. Three new directors joined in April 2025: Dawn Fitzpatrick (ex-Soros Fund Management CIO), Robert Sweeney (Sycamore Partners president, PE retail specialist), and Eugene Smith. Mohamed El-Erian serves as lead independent director. New CFO Reza Taleghani (ex-Samsonite, since February 2026) brings strong institutional finance pedigree. Eric Liedtke, the ex-Adidas brand president who joined as CMO/Strategy in August 2024, is the standout operating hire.

Insider behavior tells a split story. Fairfax Financial (Prem Watsa) purchased 13.2 million shares for $67.4 million in January 2026 and added another 1.18 million shares in May 2026. But Plank himself has made no open-market purchases at multi-year lows — a notable absence for the founder-CEO of a company he controls through Class B voting shares. The PSU compensation hurdle requiring a $13 stock price by March 2028 (stock: ~$5) may now be unreachable, introducing either alignment risk or excessive risk-taking incentive.

At $5.16, Under Armour trades at 21.45x trailing EV/EBITDA — 45% above its five-year average of 14.75 and 43% above the peer median of approximately 15x. The trailing P/E is negative (TTM EPS approximately -$0.03). Forward P/E is approximately 28x based on FY2027 consensus of ~$0.12 — a multiple that requires the turnaround to succeed and then accelerate.

The probability-weighted fair value from Turnaround Radar's scenario analysis is $4.90: 20% × $7.00 (strong turnaround) + 40% × $4.50 (slow grind) + 30% × $3.00 (stall) + 10% × $8.00 (takeout). The current price sits 5-14% above this target, meaning the downside scenarios (70% combined probability weight) dominate. Even the P/S ratio of 0.50, which looks superficially cheap, flatters a business that is currently losing money.

Fairfax remains the sole meaningful buyer. Management insiders — including Plank — are not deploying personal capital into the stock at these prices. This divergence between a strategic investor accumulating and a founder not buying is a valuation signal in itself: Fairfax may be buying for optionality on a take-private at a known price, while management knows the near-term earnings trajectory better than the market.

The AVOID verdict is driven by the moat assessment. The decision matrix is clear: an eroding moat produces an AVOID regardless of how fixable the crisis is, how adequate the management team is, or how the valuation looks. This is not an arbitrary rule — it reflects the empirical pattern that turnarounds with weakening competitive moats fail more often than they succeed, even with competent leadership.

The four specialist findings reinforce rather than contradict this conclusion. The Crisis Diagnostician confirms real operating deterioration. The Capability Assessor credits Plank's plan but flags zero turnaround precedent and no personal buying. The Valuation Analyst demonstrates that the stock embeds a turnaround premium that multiples, peers, and scenario math all reject. Conviction is HIGH because all signals point the same direction: the thesis is not ambiguous, only the timeline of resolution is uncertain.

This analysis is research, not investment advice. The TR research it's built on is at turnaroundradar.com. For all current verdicts across the portfolio, see The Verdict Board.